Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Guibert

Showing results (11-20 of 12) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 12 results.
Frontiers in Oncology|October 11, 2021
Hyperprogressive Disease After Combined Anti-PD-L1 and Anti-CTLA-4 Immunotherapy for MSI-H/dMMR Gastric Cancer: A Case ReportRomain Varnier, Thibaut Garrivier, Emilie Hafliger, et al.
Translational Oncology|November 18, 2021
Precision medicine for patients with gastro-oesophageal cancer: A subset analysis of the ProfiLER programPhilippe A Cassier, Clémentine Peyramaure, Valery Attignon, et al.
Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 12 results.
Frontiers in Oncology|October 11, 2021
Hyperprogressive Disease After Combined Anti-PD-L1 and Anti-CTLA-4 Immunotherapy for MSI-H/dMMR Gastric Cancer: A Case ReportRomain Varnier, Thibaut Garrivier, Emilie Hafliger, et al.
Translational Oncology|November 18, 2021
Precision medicine for patients with gastro-oesophageal cancer: A subset analysis of the ProfiLER programPhilippe A Cassier, Clémentine Peyramaure, Valery Attignon, et al.
Pageof 2